{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:00:36Z","timestamp":1781712036162,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009242","name":"DHOS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jhepr.2023.100689","type":"journal-article","created":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T17:25:36Z","timestamp":1675013136000},"page":"100689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8627-9676","authenticated-orcid":false,"given":"Cyrille","family":"F\u00e9ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4903-0908","authenticated-orcid":false,"given":"Loic","family":"Campion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Mathurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Archambreaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6546-7627","authenticated-orcid":false,"given":"Xavier","family":"Mirabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Pierre","family":"Bronowicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1785-6329","authenticated-orcid":false,"given":"Emmanuel","family":"Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Perret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Mineur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Oberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Touchefeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9160-9369","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Gournay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6810-9406","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Regnault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Edeline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Rode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hillion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Fr\u00e9d\u00e9ric","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Nguyen","family":"Khac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0331-9474","authenticated-orcid":false,"given":"Alain","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena Galetto","family":"Preglisasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Faurel-Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Auble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Mornex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Merle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100689_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100689_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100689_bib3","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.18632\/oncotarget.13813","article-title":"Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhepr.2023.100689_bib4","first-page":"CD012244","article-title":"Transcatheter arterial chemoembolisation followed by three-dimensional conformal radiotherapy versus transcatheter arterial chemoembolisation alone for primary hepatocellular carcinoma in adults","volume":"2","author":"Lu","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhepr.2023.100689_bib5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaoncol.2015.2189","article-title":"Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"1","author":"Huo","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhepr.2023.100689_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1053\/j.gastro.2021.06.008","article-title":"Evidence-based management of hepatocellular carcinoma: systematic review and meta-analysis of randomized controlled trials (2002\u20132020)","volume":"161","author":"Haber","year":"2021","journal-title":"Gastroenterology"},{"issue":"Suppl. 4","key":"10.1016\/j.jhepr.2023.100689_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1634\/theoncologist.2010-S4-42","article-title":"Treatment of intermediate\/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?","volume":"15","author":"Lencioni","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.jhepr.2023.100689_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100689_bib9","unstructured":"National Cancer NIH. Institute Common Terminology Criteria for Adverse Events, version 4.0. http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_5 7.pdf."},{"key":"10.1016\/j.jhepr.2023.100689_bib10","first-page":"39","article-title":"Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for inoperable primary liver cancer","volume":"15","author":"Zhao","year":"2006","journal-title":"Chin J Radiat Oncol"},{"key":"10.1016\/j.jhepr.2023.100689_bib11","first-page":"3140","article-title":"Prospective randomized clinical study of transcatheter arterial chemoembolization, combined with three-dimensional conformal radiotherapy for primary liver cancer: an analysis of 40 cases","volume":"15","author":"Shang","year":"2007","journal-title":"Shijie Xiaohua Zazhi"},{"key":"10.1016\/j.jhepr.2023.100689_bib12","first-page":"18","article-title":"Transcatheter arterial chemoembolization combined with 3-dimensional conformal radiotherapy for patients with unresectable primary hepatic carcinoma","volume":"35","author":"Xiao","year":"2008","journal-title":"Chin J Clin Oncol"},{"key":"10.1016\/j.jhepr.2023.100689_bib13","first-page":"1896","article-title":"Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma","volume":"30","author":"Ning","year":"2009","journal-title":"Sichuan Med J"},{"key":"10.1016\/j.jhepr.2023.100689_bib14","first-page":"634","article-title":"Effects of transcatheter arterial chemoembolization (TACE) versus TACE combined with three dimensional radiation (3-DCRT) in the treatment of patients with primary hepatocellular carcinoma","volume":"26","author":"Gong","year":"2011","journal-title":"Pract J Cancer"},{"key":"10.1016\/j.jhepr.2023.100689_bib15","first-page":"506","article-title":"Effect comparison of TACE plus 3DCRT and TACE alone in the treatment of primary hepatic cancer","volume":"24","author":"Xiao","year":"2011","journal-title":"J\u00a0Basic Clin Oncol"},{"key":"10.1016\/j.jhepr.2023.100689_bib16","first-page":"692","article-title":"Three-dimensional conformal radiotherapy in combination with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma","volume":"19","author":"Chen","year":"2014","journal-title":"J\u00a0BUON"},{"key":"10.1016\/j.jhepr.2023.100689_bib17","first-page":"681","article-title":"Three dimensional conformal radiotherapy combined with interventional therapy for primary hepatocellular carcinoma","volume":"25","author":"Liao","year":"2010","journal-title":"J\u00a0Prac Oncol"},{"key":"10.1016\/j.jhepr.2023.100689_bib18","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhepr.2023.100689_bib19","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jhep.2019.08.006","article-title":"Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma","volume":"71","author":"Ricke","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100689_bib20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.canrad.2017.07.040","article-title":"[Stereotactic body radiotherapy for liver tumors: state of the art]","volume":"21","author":"Riou","year":"2017","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.jhepr.2023.100689_bib21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijrobp.2019.12.004","article-title":"Curative irradiation treatment of hepatocellular carcinoma: a multicenter phase 2 trial","volume":"107","author":"Durand-Labrunie","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jhepr.2023.100689_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12885-019-5461-3","article-title":"Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Cancer"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923000204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923000204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:30:28Z","timestamp":1762900228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923000204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2589555923000204"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100689","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100689"}}